JOHN H POWERS III, MD

Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.

Temple University School Of Medicine - Philadelphia PA
Rank: Instructor
Years: 1991-1992

Jefferson Medical College Of Thomas Jefferson University - Philadelphia PA
Rank: Assistant Professor
Years: 1995-1997

University Of Maryland School Of Medicine - Baltimore MD
Rank: Assistant Professor
Years: 1997-present

George Washington University School Of Medicine And Health Sciences - Washington DC
Rank: Assistant Professor
Years: 2000-present

George Washington University School Of Medicine And Health Sciences - Washington DC
Rank: Associate Professor
Years: 2000-present

George Washington University School Of Medicine And Health Sciences - Washington DC
Rank: Full Professor
Years: 2000-present

None Reported

Patient-reported outcomes to support medical product labeling claims: FDA perspective.
Value Health
10 Suppl 2:S125-37
Date: 11 2007

Noninferiority and equivalence trials: deciphering 'similarity' of medical interventions
Stat Med
27(3):343-52
Date: 02 2008

Reassessing the design, conduct, and analysis of clinical trials of therapy for community-acquired pneumonia
Clin Infect Dis
46(8):1152-6
Date: 04 2008

World Health Organization ranking of antimicrobials according to their importance in human medicine: A critical step for developing risk management strategies for the use of antimicrobials in food production animals.
Clin Infect Dis
49(1):132-41
Date: 07 2009

Progress in the Fight Against Multidrug-Resistant Bacteria? A Review of U.S. Food and Drug Administration-Approved Antibiotics, 2010-2015.
Annals of Internal Medicine
165(5):363-72
Date: 09 2016

Clinician-Reported Outcome Assessments of Treatment Benefit: Report of the ISPOR Clinical Outcome Assessment Emerging Good Practices Task Force.
Value in Health
20(1):2-14.
Date: 01 2017

Informed Consent to Study Purpose in Randomized Clinical Trials of Antibiotics, 1991 Through 2011.
JAMA Internal Medicine
177(10):1-8
Date: 10 2017

Reliability, Validity, and Responsiveness of InFLUenza Patient-Reported Outcome (FLU-PRO©) Scores in Influenza-Positive Patients.
Value in Health
21(2):210-218
Date: 02 2018

Studying new antibiotics for multidrug resistant infections: are today's patients paying for unproved future benefits?
BMJ
360:k587.
Date: 02 2018

Performance of the inFLUenza Patient-Reported Outcome (FLU-PRO) diary in patients with influenza-like illness (ILI).
PLOS One
22;13(3)
Date: 03 2018